Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia

J Björkander; J Nikoskelainen; H Leibl; JT Lumio

Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia

J Björkander
, J Nikoskelainen
, H Leibl
, JT Lumio

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

43 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	286-293
Julkaisu	Vox Sanguinis
Vuosikerta	90
Numero	4
Tila	Julkaistu - 2006
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Pääsy asiakirjaan

https://pubmed.ncbi.nlm.nih.gov/16635071

Siteeraa tätä

@article{e0219bd3805a44898fa29619d46f46d1,

title = "Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10\% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia",

author = "J Bj{\"o}rkander and J Nikoskelainen and H Leibl and JT Lumio",

year = "2006",

language = "English",

volume = "90",

pages = "286--293",

journal = "Vox Sanguinis",

issn = "0042-9007",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "4",

}

TY - JOUR

T1 - Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia

AU - Björkander, J

AU - Nikoskelainen, J

AU - Leibl, H

AU - Lumio, JT

PY - 2006

Y1 - 2006

M3 - Article

SN - 0042-9007

VL - 90

SP - 286

EP - 293

JO - Vox Sanguinis

JF - Vox Sanguinis

IS - 4

ER -